BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

21 related articles for article (PubMed ID: 8744723)

  • 1. Association of recipient and donor interleukin 6 polymorphisms 174 and 597 with outcome after allogeneic hematopoietic stem cell transplantation in children.
    Wetzel L; Wittig S; Gruhn B
    J Cancer Res Clin Oncol; 2022 Jan; 148(1):255-265. PubMed ID: 34120222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aberrant HLA-DR expression in the conjunctival epithelium after autologous serum treatment in patients with graft-versus-host disease or Sjögren's syndrome.
    Jirsova K; Seidler Stangova P; Palos M; Mahelkova G; Kalasova S; Rybickova I; Utheim TP; Vesela V
    PLoS One; 2020; 15(4):e0231473. PubMed ID: 32315325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinetics of gene expression in murine cutaneous graft-versus-host disease.
    Sugerman PB; Faber SB; Willis LM; Petrovic A; Murphy GF; Pappo J; Silberstein D; van den Brink MR
    Am J Pathol; 2004 Jun; 164(6):2189-202. PubMed ID: 15161652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of IL-18 and sIL2R on aGVHD occurrence after hematopoietic stem cell transplantation in some Iranian patients.
    Shaiegan M; Iravani M; Babaee GR; Ghavamzadeh A
    Transpl Immunol; 2006 Jan; 15(3):223-7. PubMed ID: 16431290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adhesion molecule expression in human hepatic graft-versus-host disease.
    Norton J; al-Saffar N; Sloane JP
    Bone Marrow Transplant; 1992 Aug; 10(2):153-6. PubMed ID: 1381979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes of cytokines during the course of graft-versus-host disease following bone marrow transplantation: a case report.
    Takatsuka H; Takemoto Y; Okada M; Sawada A; Katsuno T; Wada H; Kakishita E
    Cytokine; 2000 Aug; 12(8):1225-7. PubMed ID: 10930300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinetics of serum cytokines after allogeneic bone marrow transplantation: interleukin-5 as a potential marker of acute graft-versus-host disease.
    Imoto S; Oomoto Y; Murata K; Das H; Murayama T; Kajimoto K; Sugimoto T; Gomyo H; Nakagawa T; Nishimura R; Koizumi T
    Int J Hematol; 2000 Jul; 72(1):92-7. PubMed ID: 10979216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunophenotypic profile of peripheral blood eosinophils in acute graft-vs.-host disease.
    Rumi C; Rutella S; Bonini S; Bonini S; Lambiase A; Sica S; Puggioni P; Salutari P; Etuk B; Leone G
    Exp Hematol; 1998 Feb; 26(2):170-8. PubMed ID: 9472806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular infiltrates in the target organs associated with acute graft-versus-host disease.
    Renkonen R; Häyry P
    Bone Marrow Transplant; 1987 Dec; 2(4):333-46. PubMed ID: 3332181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytokine cascades in acute graft-versus-host disease.
    Krenger W; Hill GR; Ferrara JL
    Transplantation; 1997 Aug; 64(4):553-8. PubMed ID: 9293864
    [No Abstract]   [Full Text] [Related]  

  • 11. Cytokines, adhesion molecules (E-selectin and VCAM-1) and graft-versus-host disease.
    Lange A; Klimczak A; Karabon L; Suchnicki K
    Arch Immunol Ther Exp (Warsz); 1995; 43(2):99-105. PubMed ID: 8744723
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.